| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |